Treatment with an anti-CD44 mAb strongly decreased HA-coated nanoparticle-induced cell cytotoxicity in MDA-MB-231 cells, but no obvious effects were noted in CV-1 cells (Fig. 3D), suggesting that activated CD44 mediates the increase in breast cancer cell selective cytotoxicity. The gene discussed is CD44; the disease is breast cancer.